vs
Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $83.1M, roughly 1.1× PROCEPT BioRobotics Corp). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -98.1%, a 60.0% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 20.2%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 24.8%).
Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
HIVE vs PRCT — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $93.1M | $83.1M |
| Net Profit | $-91.3M | $-31.6M |
| Gross Margin | -27.1% | 64.9% |
| Operating Margin | — | -4.1% |
| Net Margin | -98.1% | -38.1% |
| Revenue YoY | 218.6% | 20.2% |
| Net Profit YoY | -234.0% | -27.9% |
| EPS (diluted) | $-0.38 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $93.1M | $76.4M | ||
| Q3 25 | $87.3M | $83.3M | ||
| Q2 25 | $45.6M | $79.2M | ||
| Q1 25 | — | $69.2M | ||
| Q4 24 | $29.2M | $68.2M | ||
| Q3 24 | $22.6M | $58.4M | ||
| Q2 24 | $32.2M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $-91.3M | $-29.8M | ||
| Q3 25 | $-15.8M | $-21.4M | ||
| Q2 25 | $35.0M | $-19.6M | ||
| Q1 25 | — | $-24.7M | ||
| Q4 24 | $68.2M | $-18.9M | ||
| Q3 24 | $80.0K | $-21.0M | ||
| Q2 24 | $-18.3M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | -27.1% | 60.6% | ||
| Q3 25 | 4.7% | 64.8% | ||
| Q2 25 | -13.6% | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | -43.7% | 64.0% | ||
| Q3 24 | -66.1% | 63.2% | ||
| Q2 24 | -7.4% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | — | -40.6% | ||
| Q3 25 | — | -27.8% | ||
| Q2 25 | — | -28.0% | ||
| Q1 25 | — | -39.7% | ||
| Q4 24 | — | -28.9% | ||
| Q3 24 | — | -38.4% | ||
| Q2 24 | — | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | -98.1% | -39.1% | ||
| Q3 25 | -18.1% | -25.7% | ||
| Q2 25 | 76.8% | -24.7% | ||
| Q1 25 | — | -35.8% | ||
| Q4 24 | 233.2% | -27.6% | ||
| Q3 24 | 0.4% | -35.9% | ||
| Q2 24 | -56.7% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $-0.38 | $-0.54 | ||
| Q3 25 | $-0.07 | $-0.38 | ||
| Q2 25 | $0.18 | $-0.35 | ||
| Q1 25 | — | $-0.45 | ||
| Q4 24 | $0.52 | $-0.34 | ||
| Q3 24 | $0.00 | $-0.40 | ||
| Q2 24 | $-0.17 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $559.3M | $347.7M |
| Total Assets | $624.0M | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | — | $286.5M | ||
| Q3 25 | — | $294.3M | ||
| Q2 25 | — | $302.7M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | $40.5M | $333.7M | ||
| Q3 24 | $31.7M | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $559.3M | $365.9M | ||
| Q3 25 | $624.6M | $380.3M | ||
| Q2 25 | $560.5M | $385.8M | ||
| Q1 25 | — | $389.2M | ||
| Q4 24 | $430.9M | $402.2M | ||
| Q3 24 | $275.5M | $241.2M | ||
| Q2 24 | $268.6M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $624.0M | $508.1M | ||
| Q3 25 | $693.0M | $511.5M | ||
| Q2 25 | $628.7M | $513.1M | ||
| Q1 25 | — | $519.4M | ||
| Q4 24 | $478.6M | $534.0M | ||
| Q3 24 | $334.7M | $374.1M | ||
| Q2 24 | — | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $46.0M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $46.0M | $-10.3M | ||
| Q3 25 | $-10.6M | $-6.6M | ||
| Q2 25 | $10.2M | $-15.0M | ||
| Q1 25 | — | $-17.0M | ||
| Q4 24 | $-28.5M | $-32.4M | ||
| Q3 24 | $-2.2M | $-18.8M | ||
| Q2 24 | $-4.4M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-12.2M | ||
| Q3 25 | — | $-9.5M | ||
| Q2 25 | — | $-17.8M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | $-55.5M | $-33.6M | ||
| Q3 24 | $-34.7M | $-19.0M | ||
| Q2 24 | — | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -15.9% | ||
| Q3 25 | — | -11.4% | ||
| Q2 25 | — | -22.5% | ||
| Q1 25 | — | -27.2% | ||
| Q4 24 | -189.9% | -49.2% | ||
| Q3 24 | -153.4% | -32.6% | ||
| Q2 24 | — | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | 92.5% | 1.7% | ||
| Q3 24 | 143.9% | 0.4% | ||
| Q2 24 | — | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.29× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.42× | — | ||
| Q3 24 | -26.94× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HIVE
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
